Novo Nordisk A Asset Turnover Ratio (NVO), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Novo Nordisk A  (NYSE: NVO)
 

Novo Nordisk A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Novo Nordisk A asset turnover ratio, the ability of Novo Nordisk A's assets to generate revenue in the first quarter 2026, increased sequentially to 0.62 in the first quarter (Mar 31 2026), yet the ratio remained below the average, as NVO's position remain challenging.

Within sector 71 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 1991, from total ranking in the fourth quarter 2025 at 1994.

Asset Turnover Ratio Definition



NVO Asset Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Asset Change 1.07 % -76.33 % 35.54 % 43.37 % 97.24 %
Y / Y Revenue Change 37.57 % 0.7 % 11.78 % 18.95 % 15.86 %
Asset Turnover Ratio (TTM) 0.62 0.57 0.31 0.31 0.31
NVO's Total Ranking # 1991 # 1994 # # #
Seq. Asset Change 1.07 % 5.92 % 5.88 % -10.84 % -76.33 %
Seq. Revenue Change 22.55 % 5.42 % 0.48 % 5.98 % -10.3 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 72
Healthcare Sector # 278
Overall Market # 1991

Asset Turnover Ratio Statistics
High Average Low
1.04 0.78 0.57
(Dec 31 2018)   (Dec 31 2025)







Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Star Equity Holdings Inc   1.62 $ 178.521  Millions$ 110.325  Millions
Chemed Corporation  1.58 $ 2,540.548  Millions$ 1,603.867  Millions
Koru Medical Systems Inc   1.58 $ 43.257  Millions$ 27.353  Millions
Adm Tronics Unlimited Inc   1.57 $ 3.347  Millions$ 2.126  Millions
Interpace Biosciences Inc   1.56 $ 35.664  Millions$ 22.905  Millions
Marpai Inc  1.50 $ 17.125  Millions$ 11.408  Millions
Kewaunee Scientific Corporation  1.49 $ 280.595  Millions$ 188.882  Millions
Qhslab Inc   1.48 $ 2.775  Millions$ 1.876  Millions
Nephros Inc   1.47 $ 19.464  Millions$ 13.231  Millions
Viemed Healthcare Inc   1.46 $ 286.565  Millions$ 195.870  Millions
Evofem Biosciences Inc   1.45 $ 20.237  Millions$ 13.976  Millions
Medpace Holdings Inc   1.44 $ 2,678.268  Millions$ 1,857.442  Millions
Infusystem Holdings Inc  1.43 $ 142.404  Millions$ 99.737  Millions
Medinotec Inc   1.42 $ 9.729  Millions$ 6.849  Millions
Sonoma Pharmaceuticals Inc   1.39 $ 19.529  Millions$ 14.026  Millions
Vaxart Inc   1.38 $ 255.609  Millions$ 184.802  Millions
Karyopharm Therapeutics Inc   1.37 $ 151.118  Millions$ 110.236  Millions
Sanara Medtech Inc   1.37 $ 106.873  Millions$ 78.019  Millions
Evolus Inc   1.35 $ 302.349  Millions$ 223.579  Millions
Aveanna Healthcare Holdings Inc   1.32 $ 2,521.890  Millions$ 1,903.964  Millions
Edap Tms Sa  1.32 $ 112.115  Millions$ 84.737  Millions
Idexx Laboratories Inc  1.32 $ 4,445.939  Millions$ 3,363.440  Millions
Electromed Inc   1.28 $ 70.478  Millions$ 55.173  Millions
Tactile Systems Technology Inc   1.27 $ 343.414  Millions$ 269.571  Millions
Elite Pharmaceuticals Inc   1.27 $ 147.000  Millions$ 115.816  Millions
Rosecliff Acquisition Corp I  1.27 $ 20.547  Millions$ 16.202  Millions
Xtant Medical Holdings Inc   1.27 $ 121.001  Millions$ 95.486  Millions
Hca Healthcare Inc   1.27 $ 76,388.000  Millions$ 60,363.250  Millions
Avita Medical Inc   1.26 $ 72.347  Millions$ 57.450  Millions
Precipio inc   1.26 $ 25.831  Millions$ 20.522  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.